Erytech Pharma S.A.
LYON, France, March 12, 2019 (GLOBE NEWSWIRE) --
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon - France
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com
Date | Total of shares composing the share capital |
Total of brut(1)
voting rights |
Total of net(2)
voting rights |
December 31, 2018 | 17 940 035 | 19 525 606 | 19 523 106 |
January 31, 2019 | 17 940 035 | 19 525 918 | 19 523 418 |
February 28, 2019 | 17 940 035 | 19 525 792 | 19 523 292 |
(1)
Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this
number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights
.
(2) Without treasury shares.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Oma Säästöpankki Oyj4.8.2025 08:25:00 CEST | Press release
Updated composition of the management team of Oma Savings Bank
Totalkredit A/S4.8.2025 08:25:00 CEST | Press release
Prepayments (CK93) - Totalkredit A/S
Nykredit Realkredit A/S4.8.2025 08:25:00 CEST | Pressemeddelelse
Ekstraordinære indfrielser (CK93) - Nykredit Realkredit A/S
Nykredit Realkredit A/S4.8.2025 08:25:00 CEST | Press release
Prepayments (CK93) - Nykredit Realkredit A/S
Totalkredit A/S4.8.2025 08:25:00 CEST | Pressemeddelelse
Ekstraordinære indfrielser (CK93) - Totalkredit A/S
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom